CoChat

Exploring the Prevalence and Risk Factors of MASLD in Patients with Newly Diagnosed Diabetes Mellitus: A Comprehensive Investigation

Open access
Beyazal Polat, Hatice, Beyazal, Mehmet, Arpa, Medeni, Kızılkaya, Bayram, Ayaz, Teslime, Gündoğdu, Ömer Lütfi, Konur, Kamil, Polat, Zehra, Beyazal Çeliker, Fatma, Atasoy, Halil · 2025 · Journal of Clinical Medicine

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Abstract

Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) represents a growing concern in the context of metabolic disorders, particularly among individuals diagnosed with type 2 diabetes mellitus (T2DM). This study aimed to investigate the prevalence of MASLD among newly diagnosed T2DM patients and identify the risk factors for MASLD in this population. Methods: This prospective study included 128 patients with newly diagnosed T2DM between January 2022 and June 2023. Demographic, clinical, anthropometric (BMI, waist circumference), and laboratory data (glucose, HbA1c, lipid profile, ALT, AST, creatinine, platelet count) were collected. MASLD was diagnosed based on ultrasonographic evidence of hepatic steatosis with at least one cardiometabolic risk factor after excluding other causes. Linear regression models were used to determine independent predictors. Results: MASLD was detected in 80.4% of patients. Compared with the MASLD (−) group, the MASLD (+) group had significantly higher ALT (47.1 ± 23 U/L vs. 24.9 ± 8 U/L, p < 0.001) and non-HDL cholesterol (189 ± 57 mg/dL vs. 167 ± 28 mg/dL, p = 0.047). Spearman correlation showed positive associations of MASLD severity with waist circumference, LDL cholesterol, and platelet count. ALT and BMI were independently associated with MASLD in linear regression analysis. Conclusions: This study underscores the significant prevalence of MASLD in newly diagnosed T2DM patients, emphasizing the relevance of early detection in addressing this common comorbidity in the diabetic population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm14103513

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart illustrating patient selection, exclusion criteria, and group classification based on the presence or absence of MASLD.
Figure 1 Flowchart illustrating patient selection, exclusion criteria, and group classification based on the presence or absence of MASLD.CC BY · PubMed Central
Figure 2 Association between MASLD grades and waist circumference. Higher grades of steatosis were associated with increased waist circumference, reflecting greater central obesity.
Figure 2 Association between MASLD grades and waist circumference. Higher grades of steatosis were associated with increased waist circumference, reflecting greater central obesity.CC BY · PubMed Central
Figure 3 Relationship between MASLD grades and LDL cholesterol levels. A stepwise increase in LDL levels was observed with increasing steatosis severity, underlining the link between hepatic fat accumulation and dyslipidemia.
Figure 3 Relationship between MASLD grades and LDL cholesterol levels. A stepwise increase in LDL levels was observed with increasing steatosis severity, underlining the link between hepatic fat accumulation and dyslipidemia.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 1

  1. Atan, 2017, Type 2 diabetes mellitus and non-alcoholic fatty liver disease: A systematic review and meta-analysis, Gastroenterol. Hepatol. Bed. Bench., 10, S1

Cited by

See all 14

Metadata

Authors
Beyazal Polat, H., Beyazal, M., Arpa, M., Kızılkaya, B., Ayaz, T., Gündoğdu, Ö. L., Konur, K., Polat, Z., Beyazal Çeliker, F., & Atasoy, H.
Affiliations
  • Recep Tayyip Erdoğan University Faculty of Medicine, 53100 Rize, Türkiye
  • Recep Tayyip Erdoğan University (TR)
  • Rize Chambers and Commodity Exchanges Union Science High School, 53020 Rize, Türkiye
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2025-05-17
Volume
14
Issue
10
Pages
3513
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4410501420
Cited by
13
References
35
Citations by year
2026: 12 · 2025: 1
FWCI
9.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
non-alcoholic fatty liver disease, type 2 diabetes, newly diagnosed diabetes, prevalence, risk factors, hepatic steatosis, ALT, non-HDL cholesterol, waist circumference, body mass index, platelet count, LDL cholesterol, comorbidities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploring the Prevalence and Risk Factors of MASLD in Patients with Newly Diagnosed Diabetes Mellitus: A Comprehensive Investigation. https://app.cochat.ai/papers/10.3390/jcm14103513
The paper
Beyazal Polat, H., Beyazal, M., Arpa, M., Kızılkaya, B., Ayaz, T., Gündoğdu, Ö. L., Konur, K., Polat, Z., Beyazal Çeliker, F., & Atasoy, H. (2025). Exploring the Prevalence and Risk Factors of MASLD in Patients with Newly Diagnosed Diabetes Mellitus: A Comprehensive Investigation. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14103513

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.